Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Haemonetics Corp (NYSE:HAE)

57.84
Delayed Data
As of 4:02pm ET
 +0.74 / +1.30%
Today’s Change
36.44
Today|||52-Week Range
58.99
+43.88%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Quarter
Trend
Quarter 4
2016
Quarter 1
2017
Quarter 2
2017
Quarter 3
2017
Revenue and IncomeNet Revenues227.8M228.1M211.0M225.4M
 
 
 
 
 
Cost of Goods Sold104.5M107.8M97.5M98.6M
 
 
 
 
 
Depreciation And Amortization22.3M22.2M21.8M22.2M
 
 
 
 
 
 
Operating ExpensesGross Income101.1M98.1M91.7M104.6M
 
 
 
 
 
General Expenses72.7M82.4M72.5M74.4M
 
 
 
 
 
Research And Development8.5M9.3M8.2M7.5M
 
 
 
 
 
Total Operating Expenses199.4M212.4M191.8M195.2M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income28.4M15.7M19.1M30.1M
 
 
 
 
 
Extraordinary Credit2.0M--99.0K181.0K
 
 
 
 
Extraordinary Charge-7.2M-73.2M-2.5M-5.8M
 
 
 
 
 
Interest Expense On Debt4.3M1.7M1.5M1.6M
 
 
 
 
 
Other Expenses0.000.008.0M-91.0K
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income18.9M-59.2M23.3M22.9M
 
 
 
 
 
Income Taxes-3.5M-8.0M-3.1M-2.8M
 
 
 
 
 
Net Income15.4M-51.1M20.1M20.1M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS51.7M52.0M52.4M52.6M
 
 
 
 
 
Shares To Calculate EPS Diluted52.1M52.0M52.8M53.0M
 
 
 
 
 
 
Earnings Per ShareEPS$0.30-$0.98$0.38$0.38
 
 
 
 
 
EPS Diluted$0.30-$0.98$0.38$0.38